Im raising the capital for QBiotics which will go to funding human trials via the FDA. As the OIS states, we are raising $10m so that the drug EBC-46 can enter trials early next year (quite a bit of prep work to do before phase 1 trials start). The trials will be run in Australia and will be to FDA standard. As QBiotics we plan to take EBC-46 through to Phase II and then exit to one of the large pharma groups who is big in Oncology. Phase III gets expensive and can cost up to $500m to run so our strategy is simply to successfully prove the drug in Phase II and then sell.
Registration in the Vet market in Australia is happening now and initial sales will commence in the next 6 months.
No IPO planned as we dont see a need because of the 2 to 3 year exit horizon. And we dont seem to have too many problems raising the funding at the moment. Most Biotechs IPO because they cant raise the funding privately, but IPO is not necessarily the right route for QBiotics at this time.
There's been over 150 case studies to date. Elton's testimonial was used last year in the Sunrise report. I guess they had their reasons to use him, strong emotional connection to his dog etc to help with the story, you know the usual drama that comes from Aussie TV. It wouldn't make sense to fill the entire OIS with testimonials, it works in animals.
I think you missed my point. My point: credibility.
With over 100 so called case studies (non in any validated scientific journals), why is the only one in the document from the brother of the Company’s Corporate Finance Manager? For real credibility:
1. have some independant scientific verification (what have they to lose, they state their IP is protected)
2. have some real world happy pet owners (surely with over 100 case studies, there must be at least one non related really happy pet owner due to their pet's cancer being removed/cured).
I'm being cautious on this listing due to the 'testimonials' from the information statement, specifically page 32.
If there have been 100 case studies, why the need for Elton Buchanan (the brother of Reuben Buchanan, the Company’s Corporate Finance Manager) to be the only successful outcome example of the two testimonials in the document?
Reuben Buchanan?
Is the exit planned during the Phase II trial or upon it's completion?
Is the veterinary market sales and IP belong to the parent company Ecobiotics?
Cheers
Has anyone heard anything new on Qbiotics entering the vet markets yet? We were told it would happen in the 6 months following the capital raising in June. Time is running short on the quoted six months.
Yep, they have submitted to the APVMA already but this authority is taking their time as I dont think they have ever approved an oncology drug before. I would expect it to be given approval shortly.
Qbiotics have kindly normalized the audio level.There appears to be a recent presentation in the investor section called "QBiotics CEO Update AGM 2012", but its too quiet to hear properly.
Sounds like there's an IR job ready made for you at QBiotics! No IR firm will have gone through what a 10 year shareholder has nor know as much about the business.I have been a shareholder of QBiotics since 2012. The way things are going we will "Johnny come late"! Why is the company not more active on social media?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?